mCRPC, fase III, MK-5684 + HRT vs Abiraterone/Enzalutamide
Cutaan plaveiselcelcarcinoom of endometriumcarcinoom, fase II, favezelimab-pembrolizumab
Urotheelcelcarcinoom, fase II, cT2-4aN0 or cT1-4aN1, pre-operatieve nivolumab + relatlimab
Ovariumcarcinoom, fase II, BRCAwt, UV1-olaparib-durvalumab
Ovarium, endometrium, TNBC, fase I, B7H4xCD3 bispecifiek antilichaam
Ovariumcarcinoom, peritoneale kanker, fase I/II, hoog CA-125, cemiplimab and MUC16-antibody
Solide tumoren, fase I, MET, MET kinase inhibitor
T4N0 / st. III resectabel coloncarcinoom, fase 3, dMMR/MSI-H; Perioperatief Dostarlimab monotherapie versus SOC
Sarcomen, fase I, radiotherapie, DDR remmers
Salivary duct carcinoom, fase II, dutasteride en CAB
Deze website gebruikt cookies.
